Labiana Health (XMAD:LAB) Short-Term Capital Lease Obligation : €0.62 Mil (As of Dec. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Short-Term Capital Lease Obligation?

Labiana Health's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2022 was €0.62 Mil.

Labiana Health's quarterly Short-Term Capital Lease Obligation declined from Dec. 2021 (€0.49 Mil) to Jun. 2022 (€0.49 Mil) but then increased from Jun. 2022 (€0.49 Mil) to Dec. 2022 (€0.62 Mil).

Labiana Health's annual Short-Term Capital Lease Obligation increased from Dec. 2020 (€0.46 Mil) to Dec. 2021 (€0.49 Mil) and increased from Dec. 2021 (€0.49 Mil) to Dec. 2022 (€0.62 Mil).

Labiana Health Short-Term Capital Lease Obligation Historical Data

The historical data trend for Labiana Health's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Short-Term Capital Lease Obligation Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

Short-Term Capital Lease Obligation

0.46

0.49

0.62

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
Short-Term Capital Lease Obligation	0.46	0.49	0.49	0.62

Labiana Health Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Labiana Health Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Labiana Health's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Short-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.